Literature DB >> 16230873

Decreasing LDL cholesterol and medication cost with every-other-day statin therapy.

Monika A Juszczyk1, Richard L Seip, Paul D Thompson.   

Abstract

Statins are administered daily, but because of their long half-lives, atorvastatin and rosuvastatin can be given every other day (q.o.d.). We examined the effect of q.o.d. statin therapy in 25 patients treated with either atorvastatin (mean dose, 18.8 mg q.o.d.) or rosuvastatin (mean dose, 9.7 mg q.o.d.). Low-density lipoprotein cholesterol decreased 43%, triglycerides (mean +/- SEM) decreased 22%+/-6%, and high-density lipoprotein cholesterol increased 9%+/-6% with q.o.d. atorvastatin (n=9; p<0.05 for all). Low-density lipoprotein cholesterol decreased 28%, triglycerides decreased 15%+/-6%, and high-density lipoprotein cholesterol increased 10%+/-5% with rosuvastatin q.o.d. (n=16; p<0.05 for all). We conclude that q.o.d. treatment with long-acting statins significantly improves serum lipid levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230873     DOI: 10.1111/j.0197-3118.2005.04404.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  11 in total

Review 1.  The role of red yeast rice for the physician.

Authors:  Ram Y Gordon; David J Becker
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

2.  Challenges in evidence-based medicine.

Authors:  Daniel Hewitt; Tony Richards
Journal:  Can Fam Physician       Date:  2006-01       Impact factor: 3.275

3.  Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia.

Authors:  Canna Jagdish Ghia; Archana Sushil Panda; Linesh R Khobragade; Rajesh Kumar Jha; Gautam S Rambhad
Journal:  J Clin Diagn Res       Date:  2014-03-15

Review 4.  Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.

Authors:  Yiannis S Chatzizisis; Konstantinos C Koskinas; Gesthimani Misirli; Christos Vaklavas; Apostolos Hatzitolios; George D Giannoglou
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 5.  A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms.

Authors:  Carl E Orringer; Jelani K Grant; Lale Tokgozoglu
Journal:  Curr Atheroscler Rep       Date:  2022-08-24       Impact factor: 5.967

Review 6.  How do you treat patients with myalgia who take statins?

Authors:  Saadi A Siddiqi; Paul D Thompson
Journal:  Curr Atheroscler Rep       Date:  2009-01       Impact factor: 5.113

Review 7.  Statin-Associated Muscle Disease: Advances in Diagnosis and Management.

Authors:  Beth A Taylor; Paul D Thompson
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

8.  Efficacy of alternate-day versus everyday dosing of atorvastatin.

Authors:  Sushobhan Pramanik; Asoke Kumar Das; Milan Chakrabarty; Susanta Kumar Bandyopadhyay; Mainak Ghosh; Chanchal Kumar Dalai
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

9.  Treating statin-intolerant patients.

Authors:  Marcello Arca; Giovanni Pigna
Journal:  Diabetes Metab Syndr Obes       Date:  2011-04-28       Impact factor: 3.168

Review 10.  Atorvastatin and cardiovascular risk in the elderly--patient considerations.

Authors:  Subroto Acharjee; Francine K Welty
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.